Loomis, Sayles & Company
USNA icon

Loomis, Sayles & Company’s Usana Health Sciences USNA Stock Holding History

Loomis, Sayles & Company’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-71
Closed -$9K – 940
2018
Q3 		$9K Buy
+71
New +$8.81K ﹤0.01% 826
2017
Q4 		– Sell
-481
Closed -$28K – 939
2017
Q3 		$28K Buy
481
+79
+20% +$4.67K ﹤0.01% 705
2017
Q2 		$26K Buy
+402
New +$24.8K ﹤0.01% 723

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company's USNA Position: Q4 2018 in Review

Loomis, Sayles & Company sold out of Usana Health Sciences (USNA) in Q4 2018, closing a stake of 71 shares — an estimated $9K sold.

Loomis, Sayles & Company first reported a position in USNA in Q2 2017 and held it in 3 quarters. The position peaked at $28K in Q3 2017. 190 funds tracked by Wall St. Rank hold USNA as of Q4 2018.

  • Loomis, Sayles & Company reported no remaining Usana Health Sciences position as of Q4 2018 after selling out during the quarter.
  • Loomis, Sayles & Company sold 71 Usana Health Sciences shares in Q4 2018, an estimated $9K.
  • Loomis, Sayles & Company first reported a position in Usana Health Sciences in Q2 2017 and held it in 3 quarters.
  • Loomis, Sayles & Company's Usana Health Sciences position peaked at $28K in Q3 2017.
  • 190 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2018.

Based on Loomis, Sayles & Company's 13F filing for Q4 2018, filed 14 Feb 2019.